Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Down Syndrome or Aneuploidy
and you are
This is an observational trial.
You are contributing to medical knowledge about your condition.
Show me locations

The purpose

To collect samples for the purpose of developing and optimizing an in vitro noninvasive prenatal diagnostic (NIPD) test. The NIPD test employs circulating cell free (ccff) DNA extracted from whole blood samples collected from women who are pregnant with a fetus previously determined to have a chromosomal abnormality. The NIPD result will be compared to the standard test results obtained from other test methods such as karyotype, FISH, QF-PCR, and/or any commercially available NIPD test.

Provided treatments

  • Other: Maternal blood draw of 30 to 50ml
Wondering what is the locations section for?
We will connect you to the doctor responsible for this trial and help you get more information.

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01052688. The sponsor of the trial is Sequenom, Inc. and it is looking for 300 volunteers for the current phase.
Official trial title:
Noninvasive Screening for Fetal Chromosomal Aneuploidy and Abnormality: Assay Development & Optimization in Affected Pregnancies